Category Health & IP

WHO Needs Another Year To Solve Differences On Fake Medicines, Committee Decides

Country delegates gathered Saturday at the World Health Assembly decided to give another year to a working group in charge of making recommendations on falsified medicines. Unanimously, countries decided that more time is needed to reach consensual recommendations, in particular on the prickly issue of intellectual property rights.

Workplan Of WHO Group On Neglected Diseases R&D Shows Timeline

A World Health Organization expert working group on innovative financing of research and development for diseases particularly affecting developing countries will present its inception report and work plan this week.

WHO Members On Verge Of New Framework For Pandemic Flu Response

Enthusiasm and relief were palpable at the World Health Assembly last week when member states in committee adopted a resolution on global preparedness in case of influenza pandemic, and in particular on the sharing of viruses and access to vaccines for developing countries.

WIPO Patent Law Committee: New Health Proposal, Tech Transfer Tensions

World Intellectual Property Organization members this week are engaged in substantive discussions on patent policy, including a first look at a developing country proposal on public health, a surprising debate over technology transfer, and details of a questionnaire on exceptions and limitations to patents. Also responses to first feedback on a new proposal on patent quality are expected to emerge shortly.

Bill Gates Calls For “Vaccine Decade;” Explains How Patent System Drives Public Health Aid

Microsoft legend Bill Gates is impassioned about helping to save lives as head of a large-scale foundation. Today, he explained to Intellectual Property Watch how intellectual property rights help drive that process forward and make it sustainable.

Chan: WHO Embarking On “Most Extensive” Reforms In Its History

World Health Organization Director General Margaret Chan today presented her broad vision of a reformed WHO at the opening of the annual assembly of the organisation, and said the WHO was clear of suspicion of alleged pharmaceutical industry influence on the management of the H1N1 pandemic.